3-aminobenzeneboronic acid has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Dai, W; Guo, Z; Lei, Y; Liu, S; Shi, K; Tan, D; Wang, X; Wu, M; Xue, L; Zhang, Y | 1 |
| Muruganandam, A; Mutus, B; Tannous, M | 1 |
2 other study(ies) available for 3-aminobenzeneboronic acid and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
High drug-loading gold nanoclusters for responsive glucose control in type 1 diabetes.
Topics: Animals; Blood Glucose; Boronic Acids; Cattle; Diabetes Mellitus, Type 1; Gold; Hypoglycemic Agents; Insulin; Male; Metal Nanoparticles; Mice, Inbred C57BL; Serum Albumin, Bovine | 2019 |
ELISA for in vivo assessment of nonenzymatically glycated platelet glutathione peroxidase.
Topics: Animals; Antibody Specificity; Blood Platelets; Blotting, Western; Boronic Acids; Cattle; Chromatography, Affinity; Computer Simulation; Diabetes Mellitus, Type 1; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Glutathione Peroxidase; Glycosylation; Humans; Immune Sera; Linear Models | 1994 |